MicroRNA signatures in B-cell lymphomas

Accurate lymphoma diagnosis, prognosis and therapy still require additional markers. We explore the potential relevance of microRNA (miRNA) expression in a large series that included all major B-cell non-Hodgkin lymphoma (NHL) types. The data generated were also used to identify miRNAs differentiall...

Full description

Saved in:
Bibliographic Details
Published in:Blood cancer journal (New York) 2012-02, Vol.2 (2), p.e57-e57
Main Authors: Di Lisio, L, Sánchez-Beato, M, Gómez-López, G, Rodríguez, M E, Montes-Moreno, S, Mollejo, M, Menárguez, J, Martínez, M A, Alves, F J, Pisano, D G, Piris, M A, Martínez, N
Format: Article
Language:English
Subjects:
631/1647/2217/2018
692/53/2421
692/699/67/1990/291/1621/1915
Biomedical and Life Sciences
Biomedicine
Cancer Research
Hematology
Oncology
Original
original-article
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c442t-657667df208e3bb6f1df674c4a345d439876a63bcdcf50de9c75b746db1d67fa3
cites cdi_FETCH-LOGICAL-c442t-657667df208e3bb6f1df674c4a345d439876a63bcdcf50de9c75b746db1d67fa3
container_end_page e57
container_issue 2
container_start_page e57
container_title Blood cancer journal (New York)
container_volume 2
creator Di Lisio, L
Sánchez-Beato, M
Gómez-López, G
Rodríguez, M E
Montes-Moreno, S
Mollejo, M
Menárguez, J
Martínez, M A
Alves, F J
Pisano, D G
Piris, M A
Martínez, N
description Accurate lymphoma diagnosis, prognosis and therapy still require additional markers. We explore the potential relevance of microRNA (miRNA) expression in a large series that included all major B-cell non-Hodgkin lymphoma (NHL) types. The data generated were also used to identify miRNAs differentially expressed in Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) samples. A series of 147 NHL samples and 15 controls were hybridized on a human miRNA one-color platform containing probes for 470 human miRNAs. Each lymphoma type was compared against the entire set of NHLs. BL was also directly compared with DLBCL, and 43 preselected miRNAs were analyzed in a new series of routinely processed samples of 28 BLs and 43 DLBCLs using quantitative reverse transcription-polymerase chain reaction. A signature of 128 miRNAs enabled the characterization of lymphoma neoplasms, reflecting the lymphoma type, cell of origin and/or discrete oncogene alterations. Comparative analysis of BL and DLBCL yielded 19 differentially expressed miRNAs, which were confirmed in a second confirmation series of 71 paraffin-embedded samples. The set of differentially expressed miRNAs found here expands the range of potential diagnostic markers for lymphoma diagnosis, especially when differential diagnosis of BL and DLBCL is required.
doi_str_mv 10.1038/bcj.2012.1
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3288280</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1028017246</sourcerecordid><originalsourceid>FETCH-LOGICAL-c442t-657667df208e3bb6f1df674c4a345d439876a63bcdcf50de9c75b746db1d67fa3</originalsourceid><addsrcrecordid>eNplkdtKAzEQhoMoVmpvfABZ8EJRtibZnPZGqMUTVAXR65BNsu2WPdRkV-jbm9Jaqs7NDMzHP4cfgBMEhwgm4jrT8yGGCA_RHjjCkJCYJoLu79Q9MPB-DkNQhlKUHoIexgKnmPAjcP5caNe8vYwiX0xr1XbO-qioo9tY27KMymW1mDWV8sfgIFelt4NN7oOP-7v38WM8eX14Go8msSYEtzGjnDFucgyFTbKM5cjkjBNNVEKoIUkqOFMsybTROYXGpprTjBNmMmQYz1XSBzdr3UWXVdZoW7dOlXLhikq5pWxUIX936mImp82XTLAQWMAgcLERcM1nZ30rq8KvblG1bTovEQwU4piwgJ79QedN5-pwnkRcUIwx5zRQl2sq_Ml7Z_PtMgjKlQUyWCBXFkgU4NPd9bfoz8MDcLUGfGjVU-t2Zv6X-wbbO46C</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1785222775</pqid></control><display><type>article</type><title>MicroRNA signatures in B-cell lymphomas</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Di Lisio, L ; Sánchez-Beato, M ; Gómez-López, G ; Rodríguez, M E ; Montes-Moreno, S ; Mollejo, M ; Menárguez, J ; Martínez, M A ; Alves, F J ; Pisano, D G ; Piris, M A ; Martínez, N</creator><creatorcontrib>Di Lisio, L ; Sánchez-Beato, M ; Gómez-López, G ; Rodríguez, M E ; Montes-Moreno, S ; Mollejo, M ; Menárguez, J ; Martínez, M A ; Alves, F J ; Pisano, D G ; Piris, M A ; Martínez, N</creatorcontrib><description>Accurate lymphoma diagnosis, prognosis and therapy still require additional markers. We explore the potential relevance of microRNA (miRNA) expression in a large series that included all major B-cell non-Hodgkin lymphoma (NHL) types. The data generated were also used to identify miRNAs differentially expressed in Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) samples. A series of 147 NHL samples and 15 controls were hybridized on a human miRNA one-color platform containing probes for 470 human miRNAs. Each lymphoma type was compared against the entire set of NHLs. BL was also directly compared with DLBCL, and 43 preselected miRNAs were analyzed in a new series of routinely processed samples of 28 BLs and 43 DLBCLs using quantitative reverse transcription-polymerase chain reaction. A signature of 128 miRNAs enabled the characterization of lymphoma neoplasms, reflecting the lymphoma type, cell of origin and/or discrete oncogene alterations. Comparative analysis of BL and DLBCL yielded 19 differentially expressed miRNAs, which were confirmed in a second confirmation series of 71 paraffin-embedded samples. The set of differentially expressed miRNAs found here expands the range of potential diagnostic markers for lymphoma diagnosis, especially when differential diagnosis of BL and DLBCL is required.</description><identifier>ISSN: 2044-5385</identifier><identifier>EISSN: 2044-5385</identifier><identifier>DOI: 10.1038/bcj.2012.1</identifier><identifier>PMID: 22829247</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/1647/2217/2018 ; 692/53/2421 ; 692/699/67/1990/291/1621/1915 ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Hematology ; Oncology ; Original ; original-article</subject><ispartof>Blood cancer journal (New York), 2012-02, Vol.2 (2), p.e57-e57</ispartof><rights>The Author(s) 2012</rights><rights>Copyright Nature Publishing Group Feb 2012</rights><rights>Copyright © 2012 Macmillan Publishers Limited 2012 Macmillan Publishers Limited</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c442t-657667df208e3bb6f1df674c4a345d439876a63bcdcf50de9c75b746db1d67fa3</citedby><cites>FETCH-LOGICAL-c442t-657667df208e3bb6f1df674c4a345d439876a63bcdcf50de9c75b746db1d67fa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1785222775/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1785222775?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22829247$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Di Lisio, L</creatorcontrib><creatorcontrib>Sánchez-Beato, M</creatorcontrib><creatorcontrib>Gómez-López, G</creatorcontrib><creatorcontrib>Rodríguez, M E</creatorcontrib><creatorcontrib>Montes-Moreno, S</creatorcontrib><creatorcontrib>Mollejo, M</creatorcontrib><creatorcontrib>Menárguez, J</creatorcontrib><creatorcontrib>Martínez, M A</creatorcontrib><creatorcontrib>Alves, F J</creatorcontrib><creatorcontrib>Pisano, D G</creatorcontrib><creatorcontrib>Piris, M A</creatorcontrib><creatorcontrib>Martínez, N</creatorcontrib><title>MicroRNA signatures in B-cell lymphomas</title><title>Blood cancer journal (New York)</title><addtitle>Blood Cancer Journal</addtitle><addtitle>Blood Cancer J</addtitle><description>Accurate lymphoma diagnosis, prognosis and therapy still require additional markers. We explore the potential relevance of microRNA (miRNA) expression in a large series that included all major B-cell non-Hodgkin lymphoma (NHL) types. The data generated were also used to identify miRNAs differentially expressed in Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) samples. A series of 147 NHL samples and 15 controls were hybridized on a human miRNA one-color platform containing probes for 470 human miRNAs. Each lymphoma type was compared against the entire set of NHLs. BL was also directly compared with DLBCL, and 43 preselected miRNAs were analyzed in a new series of routinely processed samples of 28 BLs and 43 DLBCLs using quantitative reverse transcription-polymerase chain reaction. A signature of 128 miRNAs enabled the characterization of lymphoma neoplasms, reflecting the lymphoma type, cell of origin and/or discrete oncogene alterations. Comparative analysis of BL and DLBCL yielded 19 differentially expressed miRNAs, which were confirmed in a second confirmation series of 71 paraffin-embedded samples. The set of differentially expressed miRNAs found here expands the range of potential diagnostic markers for lymphoma diagnosis, especially when differential diagnosis of BL and DLBCL is required.</description><subject>631/1647/2217/2018</subject><subject>692/53/2421</subject><subject>692/699/67/1990/291/1621/1915</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Hematology</subject><subject>Oncology</subject><subject>Original</subject><subject>original-article</subject><issn>2044-5385</issn><issn>2044-5385</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNplkdtKAzEQhoMoVmpvfABZ8EJRtibZnPZGqMUTVAXR65BNsu2WPdRkV-jbm9Jaqs7NDMzHP4cfgBMEhwgm4jrT8yGGCA_RHjjCkJCYJoLu79Q9MPB-DkNQhlKUHoIexgKnmPAjcP5caNe8vYwiX0xr1XbO-qioo9tY27KMymW1mDWV8sfgIFelt4NN7oOP-7v38WM8eX14Go8msSYEtzGjnDFucgyFTbKM5cjkjBNNVEKoIUkqOFMsybTROYXGpprTjBNmMmQYz1XSBzdr3UWXVdZoW7dOlXLhikq5pWxUIX936mImp82XTLAQWMAgcLERcM1nZ30rq8KvblG1bTovEQwU4piwgJ79QedN5-pwnkRcUIwx5zRQl2sq_Ml7Z_PtMgjKlQUyWCBXFkgU4NPd9bfoz8MDcLUGfGjVU-t2Zv6X-wbbO46C</recordid><startdate>20120201</startdate><enddate>20120201</enddate><creator>Di Lisio, L</creator><creator>Sánchez-Beato, M</creator><creator>Gómez-López, G</creator><creator>Rodríguez, M E</creator><creator>Montes-Moreno, S</creator><creator>Mollejo, M</creator><creator>Menárguez, J</creator><creator>Martínez, M A</creator><creator>Alves, F J</creator><creator>Pisano, D G</creator><creator>Piris, M A</creator><creator>Martínez, N</creator><general>Nature Publishing Group UK</general><general>Springer Nature B.V</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20120201</creationdate><title>MicroRNA signatures in B-cell lymphomas</title><author>Di Lisio, L ; Sánchez-Beato, M ; Gómez-López, G ; Rodríguez, M E ; Montes-Moreno, S ; Mollejo, M ; Menárguez, J ; Martínez, M A ; Alves, F J ; Pisano, D G ; Piris, M A ; Martínez, N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c442t-657667df208e3bb6f1df674c4a345d439876a63bcdcf50de9c75b746db1d67fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>631/1647/2217/2018</topic><topic>692/53/2421</topic><topic>692/699/67/1990/291/1621/1915</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Hematology</topic><topic>Oncology</topic><topic>Original</topic><topic>original-article</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Di Lisio, L</creatorcontrib><creatorcontrib>Sánchez-Beato, M</creatorcontrib><creatorcontrib>Gómez-López, G</creatorcontrib><creatorcontrib>Rodríguez, M E</creatorcontrib><creatorcontrib>Montes-Moreno, S</creatorcontrib><creatorcontrib>Mollejo, M</creatorcontrib><creatorcontrib>Menárguez, J</creatorcontrib><creatorcontrib>Martínez, M A</creatorcontrib><creatorcontrib>Alves, F J</creatorcontrib><creatorcontrib>Pisano, D G</creatorcontrib><creatorcontrib>Piris, M A</creatorcontrib><creatorcontrib>Martínez, N</creatorcontrib><collection>SpringerOpen</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Blood cancer journal (New York)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Di Lisio, L</au><au>Sánchez-Beato, M</au><au>Gómez-López, G</au><au>Rodríguez, M E</au><au>Montes-Moreno, S</au><au>Mollejo, M</au><au>Menárguez, J</au><au>Martínez, M A</au><au>Alves, F J</au><au>Pisano, D G</au><au>Piris, M A</au><au>Martínez, N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MicroRNA signatures in B-cell lymphomas</atitle><jtitle>Blood cancer journal (New York)</jtitle><stitle>Blood Cancer Journal</stitle><addtitle>Blood Cancer J</addtitle><date>2012-02-01</date><risdate>2012</risdate><volume>2</volume><issue>2</issue><spage>e57</spage><epage>e57</epage><pages>e57-e57</pages><issn>2044-5385</issn><eissn>2044-5385</eissn><abstract>Accurate lymphoma diagnosis, prognosis and therapy still require additional markers. We explore the potential relevance of microRNA (miRNA) expression in a large series that included all major B-cell non-Hodgkin lymphoma (NHL) types. The data generated were also used to identify miRNAs differentially expressed in Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL) samples. A series of 147 NHL samples and 15 controls were hybridized on a human miRNA one-color platform containing probes for 470 human miRNAs. Each lymphoma type was compared against the entire set of NHLs. BL was also directly compared with DLBCL, and 43 preselected miRNAs were analyzed in a new series of routinely processed samples of 28 BLs and 43 DLBCLs using quantitative reverse transcription-polymerase chain reaction. A signature of 128 miRNAs enabled the characterization of lymphoma neoplasms, reflecting the lymphoma type, cell of origin and/or discrete oncogene alterations. Comparative analysis of BL and DLBCL yielded 19 differentially expressed miRNAs, which were confirmed in a second confirmation series of 71 paraffin-embedded samples. The set of differentially expressed miRNAs found here expands the range of potential diagnostic markers for lymphoma diagnosis, especially when differential diagnosis of BL and DLBCL is required.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>22829247</pmid><doi>10.1038/bcj.2012.1</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2044-5385
ispartof Blood cancer journal (New York), 2012-02, Vol.2 (2), p.e57-e57
issn 2044-5385
2044-5385
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3288280
source Publicly Available Content Database; PubMed Central; Springer Nature - nature.com Journals - Fully Open Access
subjects 631/1647/2217/2018
692/53/2421
692/699/67/1990/291/1621/1915
Biomedical and Life Sciences
Biomedicine
Cancer Research
Hematology
Oncology
Original
original-article
title MicroRNA signatures in B-cell lymphomas
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T22%3A50%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MicroRNA%20signatures%20in%20B-cell%20lymphomas&rft.jtitle=Blood%20cancer%20journal%20(New%20York)&rft.au=Di%20Lisio,%20L&rft.date=2012-02-01&rft.volume=2&rft.issue=2&rft.spage=e57&rft.epage=e57&rft.pages=e57-e57&rft.issn=2044-5385&rft.eissn=2044-5385&rft_id=info:doi/10.1038/bcj.2012.1&rft_dat=%3Cproquest_pubme%3E1028017246%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c442t-657667df208e3bb6f1df674c4a345d439876a63bcdcf50de9c75b746db1d67fa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1785222775&rft_id=info:pmid/22829247&rfr_iscdi=true